http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-5160270-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21 |
| filingDate | 1999-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71af454d807c01151118c681e6ade4d8 |
| publicationDate | 2002-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CO-5160270-A1 |
| titleOfInvention | PROCEDURE TO TREAT CONGESTIVE INSUFFICIENCY |
| abstract | The present invention relates to methods for treating congestive heart failure in a mammal by administering an amount, which treats congestive heart failure, of a compound that inhibits phosphodiesterase type IV and the production of tumor necrosis factor, such as a substituted derivative of indazole, for example, a compound of formula <EMI FILE = "99066728_1" ID = "1" IMF = JPEG> Or a pharmaceutically acceptable salt thereof, formula in which R, R1 and R2 are as defined in memory of. The invention further relates to pharmaceutical compositions for the treatment of congestive heart failure comprising an amount, which treats congestive heart failure, of a compound that inhibits phosphodiesterase type IV and the production of tumor necrosis factor, such as, for example, a substituted derivative of indazole, for example, a compound of formula (I) herein, or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier, diluent or excipient. |
| priorityDate | 1909-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.